Insider Transactions in Q1 2025 at Alnylam Pharmaceuticals, Inc. (ALNY)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 27
2025
|
Pushkal Garg CMO & EVP Dev & Med Affairs |
SELL
Open market or private sale
|
Direct |
52,592
-81.44%
|
$14,988,720
$285.0 P/Share
|
|
Jan 27
2025
|
Pushkal Garg CMO & EVP Dev & Med Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
48,876
+32.77%
|
$4,301,088
$88.95 P/Share
|
|
Jan 23
2025
|
Phillip A Sharp Director |
SELL
Open market or private sale
|
Direct |
11,250
-100.0%
|
$3,093,750
$275.0 P/Share
|
|
Jan 23
2025
|
Phillip A Sharp Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,250
+50.0%
|
$1,473,750
$131.21 P/Share
|